The Belly Fat That Is Not About Your Belly

Opening Scene

The photograph on his phone was from a corporate retreat in 2019. He was tan, standing on a dock in shorts and a polo, holding a beer, looking like a man who had it figured out. He was 6 feet tall and 183 pounds.

He was 48 now, sitting across from me in a cardiology exam room. He weighed 196 pounds. Thirteen pounds in five years, which is not a dramatic number. But all thirteen of those pounds lived between his navel and his sternum, arranged in a way that was anatomically unmistakable. His legs were lean. His face was lean. His arms showed muscle. And his abdomen presented as a category entirely separate from the rest of his body, not soft and doughy, but firm, dense, inward-expanding, resistant to the dress shirt he had left untucked for reasons I suspected he did not want to acknowledge out loud.

His waist circumference was 38.5 inches. His blood pressure was 141 over 88. His fasting insulin was 19 µIU/mL, significantly elevated. His free testosterone was 8.3 pg/mL, low for his age. His estradiol was 44 pg/mL, elevated. He had never been diagnosed with anything. His LDL was 112 mg/dL. His primary care physician had reviewed all of this at his last physical and written “within normal limits” in the notes.

I explained to him that his abdomen was not accumulating fat. It was accumulating a metabolically active endocrine organ that had not been there five years ago.

He looked at me the way patients look when they want to understand something that no one has ever explained in plain language.

I started at the beginning.

What Most Men Hide About Visceral Fat

Irana. There is urgency in this conversation that the wellness industry consistently softens, and I want to begin with the honest version.

The emotional center of this topic is identity disruption. One post that circulates in forums reads: “I gained 90 lbs in last year and a half due to desk job, poor diet and being sedentary… I was 6’0” 180-185 lbs up until this weight gain.” (r/Testosterone) The specific dimensions, 6 feet tall, 180 to 185 pounds, are the anchor. They represent not just a weight, but a self-concept. Who a man was, what he looked like, what was available to him. The new number is not just heavier. It is evidence of a different life.

Another: “I’ve managed to gain around 20-30 pounds. My exercise routine has diminished due to increased work commitments… It feels like my body has transformed completely in just three years.” (r/AskMenOver40) Three years. That is the window where it becomes visible and feels sudden. The man in that post does not say “I gained weight.” He says his body transformed. That is not imprecision. That is an accurate description of what visceral fat accumulation does: it transforms the body’s hormonal and metabolic architecture, not just its appearance.

From r/Kettlebells4Workouts, a post that has circulated widely and for good reason: “Your visceral fat behaves like a rogue gland, elevating cortisol, lowering testosterone and growth hormone, and creating a self-sustaining fat-storage cycle that dieting alone can’t break.” (r/Kettlebells4Workouts) The phrase “rogue gland” is the most accurate non-clinical description of visceral fat I have encountered in a forum. It is not metaphor. It is biology. I will spend the next section proving it.

What men hide is the shame calculus. Belly fat in midlife is simultaneously accepted as inevitable and experienced as personal failure. The “dad bod” narrative provides cultural permission while the man himself knows that permission is covering something he cannot articulate. “I’m still gaining visceral fat and often feel weak,” reads one post, the compound of the physical and the existential in seven words. (r/Testosterone) The weakness is not imagined. The hormonal consequence of visceral fat accumulation produces real fatigue, real cognitive fog, real mood variability. He is not imagining it. He has not diagnosed it. He needs someone to explain the mechanism.

The Mechanism, In Plain English

Two kinds of fat that are not the same thing.

Your body stores fat in two primary depots. Subcutaneous fat sits between your skin and your muscle, the fat you can pinch on your arm, your thigh, your flank. This fat is metabolically relatively inert. It is an energy reserve. It is not harmless in excess, but it is not the problem I am about to describe.

Visceral fat lives inside the abdominal cavity, surrounding the organs: the liver, the intestines, the kidneys, the pancreas. You cannot see it in the mirror. You cannot pinch it. Some of it surrounds the heart itself, that is called epicardial fat, and its relationship to coronary artery disease is the specific cardiology story I will come to shortly. Visceral fat does not sit passively. It acts.

Visceral adipose tissue is metabolically active in a way subcutaneous fat is not: it secretes pro-inflammatory cytokines (IL-6, TNF-α) directly into the portal circulation, drives hepatic insulin resistance, and converts testosterone to estradiol via aromatase enzyme, creating a self-amplifying cycle of hormonal disruption, metabolic dysfunction, and further abdominal fat accumulation that makes visceral fat reduction qualitatively different from, and more urgent than, general weight loss. (Ibrahim, Obesity Reviews, 2010)

That is the citable sentence. Let me unpack it piece by piece because each element changes what you think is happening in your body.

The portal circulation and the liver.

The portal circulation is the blood supply that drains from the intestines and surrounding abdominal organs directly to the liver before entering systemic circulation. It is a private highway. The substances released by visceral fat, fatty acids, cytokines, inflammatory signals, enter this portal highway and arrive at the liver in high concentration before the rest of the body even knows they exist. The liver, exposed to this constant inflammatory load, becomes insulin resistant. It starts producing more glucose even in the fasted state. Fasting blood sugar creeps up. The pancreas produces more insulin in response. Insulin signals fat storage. More fat accumulates, more cytokines are released. The cycle continues.

This is why fasting insulin is the most important number in the metabolic assessment of a man with a growing waistline, more important than fasting glucose, more important than HbA1c in the early stages. A fasting insulin above 10 to 12 µIU/mL in a man with central adiposity is a visceral fat problem in progress. Above 20 µIU/mL, the metabolic machinery is already significantly compromised. The patient I described at the start of this article had a fasting insulin of 19. His fasting glucose was 97, technically normal. His HbA1c was 5.4, technically normal. He had none of the metabolic diagnoses that would have triggered clinical action under standard protocols. He was, by every traditional metric, fine.

The testosterone-estrogen disruption.

Visceral fat expresses high levels of aromatase enzyme, which converts testosterone to estradiol (estrogen) directly in the abdominal fat depot. Higher visceral fat = more aromatase activity = lower testosterone and higher estrogen. Estrogen then signals the hypothalamus to reduce LH (luteinizing hormone) production, further lowering testosterone, a self-amplifying cycle that cannot be broken without visceral fat reduction. (Hammoud et al., European Journal of Endocrinology, 2008)

I want to be specific about what this means clinically. A man whose free testosterone is low-normal, whose estradiol is elevated, and whose waist circumference is expanding is not experiencing primary hypogonadism. His testes are probably fine. His hypothalamus is receiving a false signal from estrogen that says “enough testosterone, stop producing.” The source of that estrogen is his visceral fat depot. You can put this man on TRT and his symptoms will improve, but you have not addressed the mechanism. You have managed the downstream effect while the upstream driver remains fully operational. Six months later his TRT dose needs increasing. His hematocrit rises. His aromatization of exogenous testosterone into estradiol is now even more pronounced because his visceral fat is still there.

This is the hormonal argument that most men’s health clinics do not make, because making it correctly requires the conversation to end with “reduce your visceral fat” rather than “increase your TRT dose.”

The cardiac anatomy story.

Epicardial fat, visceral fat that accumulates directly around the heart muscle and within the pericardial sac, is not a distant metabolic actor. It sits immediately adjacent to the coronary arteries. It secretes the same inflammatory cytokines that visceral fat secretes everywhere else, but it does so within millimeters of the coronary artery wall. The relationship between epicardial fat volume and coronary artery disease has been demonstrated in multiple imaging studies: men with greater epicardial fat burden have higher rates of coronary plaque, higher rates of atrial fibrillation, and worse outcomes after cardiac events. (Iacobellis, Nature Reviews Endocrinology, 2022)

The “dad bod” narrative treats belly fat as a cosmetic concern. In a cardiologist’s examination room, an expanding waistline with dense central adiposity is a cardiac anatomy concern. The fat surrounding your abdomen and the fat surrounding your coronary arteries are physiologically related. They are not the same tissue, but they are driven by the same mechanisms and they respond to the same interventions. Addressing visceral fat is addressing your Vascular Clock.

As a board-certified cardiologist (FACC) in active clinical practice, Dr. Job Mogire considers waist circumference and fasting insulin as essential cardiovascular biomarkers, in many ways more informative about near-term risk than the cholesterol panel that gets discussed at every annual physical. A man with a 39-inch waist, a fasting insulin of 18, and a low-normal free testosterone has a metabolic fire that his LDL of 110 is not capturing. The Vascular Clock is running fast in that man’s body, and the standard lipid panel is not the alarm.

The self-amplifying cycle, stated plainly.

Visceral fat produces estrogen. Estrogen suppresses testosterone. Low testosterone reduces muscle mass. Reduced muscle mass lowers basal metabolic rate. Lower metabolic rate makes it easier to gain more visceral fat. More visceral fat produces more estrogen. The cycle is directional and it is accelerating.

The man who says “I eat the same as I did at 35 and I’m gaining weight” is not wrong. He is describing the consequence of this cycle in operation. His basal metabolic rate has declined. His muscle-to-fat ratio has shifted. His caloric intake that was maintenance at 35 is a surplus at 47. The solution is not eating less, a caloric deficit in a man with low testosterone and reduced muscle mass preferentially loses muscle, not visceral fat. The solution requires simultaneously addressing the hormonal cycle, the insulin resistance, and the specific exercise stimulus that burns visceral fat and maintains muscle.

The Honesty Scale

Solid (strong, consistent evidence): Visceral fat as an independent cardiovascular risk factor has decades of epidemiological evidence. The aromatase-testosterone cycle is mechanistically established and clinically confirmed. The portal circulation pathway for hepatic insulin resistance driven by visceral fat cytokines is well-characterized in both animal models and human studies. The association between epicardial fat and coronary artery disease is supported by multiple cardiac imaging studies. These are not contested mechanisms.

Promising (good evidence, clinically reasonable): The specific cardiovascular risk reduction from visceral fat reduction, the degree to which losing X centimeters of waist circumference reduces cardiovascular event rates, is consistently demonstrated in observational studies and partially confirmed in clinical trial subgroup analyses. Resistant training plus aerobic training as the most effective visceral fat reduction combination has strong evidence in men. The TRT-plus-lifestyle approach for men with symptomatic low testosterone secondary to visceral fat disruption is clinically reasonable, with the caveat that hematocrit and hormonal monitoring are required.

Early (plausible mechanism, limited direct evidence): DEXA-measured visceral fat scores and InBody impedance-measured visceral fat area as clinical management guides are used in practice, but the specific clinical action thresholds (which DEXA score should trigger which intervention) are not as precisely defined in randomized trial data as blood pressure thresholds are. These tools provide useful information. They are not yet validated to the degree that blood pressure or cholesterol targets are.

Theoretical / Unsupported: Spot reduction, targeting visceral fat through abdominal exercises alone, has no meaningful evidence base. Crunches do not preferentially mobilize visceral fat. The abdominal muscle underneath visceral fat and the abdominal cavity fat are anatomically separate. Visceral fat is systemic and metabolic. It responds to systemic and metabolic interventions, not local mechanical work.

What the Other Voices Get Wrong

The weight-loss framing is the wrong framing. Most content about visceral fat, from Mayo Clinic, from Healthline, from the standard primary care conversation, frames this as a weight management problem. “Lose weight to reduce belly fat.” The mechanism is correct at the coarsest level but the prescription is insufficient and in some cases counterproductive.

A man with low testosterone, elevated insulin, and elevated visceral fat who goes on an aggressive caloric deficit without resistance training will lose muscle mass before he loses visceral fat, because low testosterone and insulin resistance shift the metabolic response to caloric restriction toward lean tissue catabolism. The scale may show a favorable number. His metabolic architecture has worsened. Body weight and visceral fat are not the same variable, and treating them as equivalent produces men who are lighter and metabolically sicker.

The waist circumference threshold of 40 inches circulates as the clinical cutoff for metabolic risk in men. (Mayo Clinic) It is a useful population-level guideline. It is not a clinical green light at 39.5 inches. The dose-response between central adiposity and cardiovascular risk is continuous. The risk at 37 inches waist circumference is lower than at 42 inches, it is not zero. Waist-to-height ratio above 0.5 is a more individually sensitive measure: a 6-foot man with a 37-inch waist (ratio 0.51) is in the elevated-risk category even below the 40-inch cutoff.

The emotional framing around visceral fat in the wellness industry oscillates between catastrophizing and enabling. The catastrophizing version makes visceral fat sound like a moral failure, the implicit message of every article illustrated with an obese belly. The enabling version is the “dad bod” acceptability narrative, which provides cultural permission for expansion without discussing the epicardial fat accumulating around the coronary arteries of the man who has accepted the narrative. Neither serves him.

The SDE position: visceral fat is not a moral category. It is a metabolic condition with specific mechanisms, specific biomarkers, and specific interventions. The identity disruption is real, “I was 185 for 20 years” is a real loss, and it is not addressed by shame or permission. It is addressed by understanding the mechanism and working with it, not against it.

Cardiologist’s Note

On the epicardial fat conversation no one is having.

When I order a cardiac CT for coronary artery calcium scoring, a test I recommend for men over 40 with any traditional cardiovascular risk factors, I look at the epicardial fat volume on the same scan. The CT captures it incidentally, and the correlation between high epicardial fat and coronary artery disease in the literature is sufficient that I treat it as clinically relevant information.

Most men who get a CAC score of zero feel completely reassured. I share their reassurance about plaque burden. But zero coronary calcium with a large epicardial fat depot on the same scan is a different risk picture than zero coronary calcium with a lean pericardial space. The inflammatory proximity of epicardial fat to the coronary vasculature is not captured by a CAC score.

I am not saying I withhold reassurance from men with zero CAC and visible epicardial fat. I am saying I use the full picture. Visceral fat reduction is on the prescription for that patient regardless of his calcium score, because the clock is running and the proximity of the inflammatory depot to his coronary arteries is a variable I can see.

The man who was 185 pounds for twenty years and is now 196, with thirteen pounds entirely in his abdomen, has a CAC score that may still be zero. His Vascular Clock is running nonetheless.

What to Do This Week

1. Measure your waist circumference at the umbilicus. Not at your belt line, which is where men tend to hold their pants at the widest comfortable point. At the navel. Do this standing, after a normal exhale, without sucking in. Write the number down. Anything above 35 inches warrants a metabolic conversation with a physician. Anything above 40 inches is a clinical action threshold regardless of everything else on your lab work.

2. Ask for fasting insulin at your next blood draw. Not fasting glucose. Not HbA1c. Fasting insulin. A result above 10 to 12 µIU/mL in a fasted state, combined with central adiposity, indicates insulin resistance in progress. This test costs less than $20 and is not included in standard panels. You have to ask for it. Most physicians will order it without objection.

3. Begin resistance training if you are not already doing it. The specific visceral fat reduction protocol with the strongest evidence combines resistance training and aerobic exercise. Neither alone is as effective as both. Resistance training preserves and builds muscle mass, increases insulin sensitivity, and raises basal metabolic rate. Two to three sessions per week of multi-joint movements, squats, deadlifts, rows, presses, is the minimum effective dose. This is not a bodybuilding prescription. It is a metabolic prescription.

4. Add 150 minutes per week of zone 2 aerobic exercise. Zone 2 training, conversational pace, 60 to 70 percent of maximum heart rate, is the most effective single aerobic stimulus for visceral fat mobilization in men over 40. The mechanism is mitochondrial: zone 2 training increases the capacity of your cells to oxidize fatty acids as fuel, which preferentially draws from visceral fat depots during extended low-intensity exercise. Three to four sessions of 40 to 45 minutes each, spread across the week.

5. Reduce refined carbohydrate intake at dinner. The evening meal is the metabolic moment where visceral fat accumulation is most sensitively modulated. Insulin sensitivity is lowest in the evening, a normal physiological pattern. A high-glycemic evening meal in an insulin-resistant man produces an exaggerated insulin response that promotes fat storage in the visceral depot overnight. This is not a prescription for no carbohydrates at dinner. It is a prescription for choosing lower-glycemic options (vegetables, legumes, whole grains) over refined carbohydrates (white rice, bread, pasta, dessert) at the meal when your insulin sensitivity is at its daily nadir.

6. Get a free testosterone and estradiol measurement. Not just total testosterone. If you are a man with visible central adiposity, low energy, and reduced libido, and your total testosterone is low-normal (350 to 500 ng/dL range), the relevant question is whether your free testosterone is adequate and whether your estradiol is elevated, the hormonal fingerprint of visceral fat-driven aromatization. This panel guides the clinical conversation about whether you need TRT, lifestyle intervention, or both, and in what sequence.

7. Do not start with a caloric deficit alone. I want to be explicit about this. In men with low testosterone and elevated insulin, aggressive caloric restriction without resistance training preferentially sacrifices muscle before visceral fat. The scale moves. The metabolic architecture deteriorates. The resistance training component is not optional if your goal is visceral fat reduction specifically, not general weight loss.

The Featured Snippet Block

Does visceral fat lower testosterone in men?

Yes. Visceral fat expresses high levels of aromatase enzyme, which converts testosterone to estradiol (estrogen) directly in the abdominal fat depot. Higher visceral fat = more aromatase activity = lower testosterone + higher estrogen. Estrogen then signals the hypothalamus to reduce LH production, further lowering testosterone, a self-amplifying cycle that cannot be broken without visceral fat reduction.

When to Call Your Cardiologist

Visceral fat is not a cardiological emergency. It is a cardiological priority. The conversations I want to have before something happens, not after.

If your waist circumference is above 40 inches and you also have any of the following, elevated blood pressure, fasting glucose above 100 mg/dL, fasting insulin above 12 µIU/mL, low HDL, elevated triglycerides, you meet criteria for metabolic syndrome. This is not a diagnosis that requires a cardiologist specifically, but it is a diagnosis that requires someone who can manage the full cardiovascular risk picture, not just the cholesterol number.

If you are on TRT and your waistline is not responding after four to six months of therapy combined with resistance training and aerobic exercise, a visceral fat assessment, either waist-to-height ratio, DEXA scan, or cardiac CT with epicardial fat measurement, is warranted to quantify the depot and track progress objectively. Subjective body image is a poor guide when the fat you cannot see (epicardial, retroperitoneal) may be persisting while subcutaneous fat reduces visibly.

If you are considering TRT specifically because of low testosterone and low energy, and you have not yet addressed visceral fat, I want to see you first. Not because TRT is wrong, it may be appropriate, but because men who begin TRT with significant visceral fat have higher rates of hematocrit elevation, more aromatization of exogenous testosterone into estradiol, and less enduring benefit than men whose visceral fat burden is reduced first. The sequence matters. The Mogire Contraindication Framework: treat the visceral fat before escalating the hormonal intervention, whenever the clinical picture permits.

The Offer Ladder

The 90-Day Vascular Reset at stopdyingearly.com is the program I built for the man in the opening scene of this article: the man who has a number on a scale and a photograph from five years ago, and no clinical framework for the distance between them.

The Reset addresses visceral fat through four simultaneous levers: resistance training protocol with specific session design for men over 40, zone 2 aerobic training built into a weekly structure that accommodates a professional’s schedule, dietary modifications calibrated for the hormonal context of midlife men (not a generic calorie-restriction plan), and biomarker tracking, waist circumference, fasting insulin, free testosterone, estradiol, at weeks zero, six, and twelve.

The program is $247. It requires a commitment to the mechanisms, not a commitment to perfection. Men who complete it consistently see waist circumference reduction of two to four inches, fasting insulin normalization, and in many cases, free testosterone increases that make TRT unnecessary or allow dose reduction.

For men who want to start with the clinical interpretation layer before committing to the full program, the Vascular Clock Starter Kit ($37) includes the visceral fat measurement guide, the fasting insulin interpretation chart, and the biomarker tracking template from the Reset.

“Now at 49, I feel significantly better compared to six years ago when I hit my heaviest. The truth is, as we age, we no longer have the youthful resilience to compensate for poor choices made in our younger years.” (r/AskMenOver40) That man found his way. The mechanism was there the whole time. He just needed someone to explain it.

Dr. Job Mogire, MD, FACP, FACC is a board-certified cardiologist in active clinical practice. He writes for stopdyingearly.com on the intersection of cardiology, men’s performance health, and evidence-based longevity. For clinical consultation, visit stopdyingearly.com.